Temporins, small antimicrobial peptides with leishmanicidal activity.
Leishmaniasis encompasses a wide range of infections caused by the human parasitic protozoan species belonging to the Leishmania genus. It appears frequently as an opportunistic disease, especially in virus-infected immunodepressed people. Similarly to other pathogens, parasites became resistant to most of the first-line drugs. Therefore, there is an urgent need to develop antiparasitic agents with new modes of action. Gene-encoded antimicrobial peptides are promising candidates, but so far only a few of them have shown anti-protozoa activities. Here we found that temporins A and B, 13-amino acid antimicrobial peptides secreted from the skin of the European red frog Rana temporaria, display anti-Leishmania activity at micromolar concentrations, with no cytolytic activity against human erythrocytes. To the best of our knowledge, temporins represent the shortest natural peptides having the highest leishmanicidal activity and the lowest number of positively charged amino acids (a single lysine/arginine) and maintain biological function in serum. Their lethal mechanism involves plasma membrane permeation based on the following data. (i) They induce a rapid collapse of the plasma membrane potential. (ii) They induce the influx of the vital dye SYTOX Green. (iii) They reduce intracellular ATP levels. (iv) They severely damage the membrane of the parasite, as shown by transmission electron microscopy. Besides giving us basic important information, the unique properties of temporins, as well as their membranolytic effect, which should make it difficult for the pathogen to develop resistance, suggest them as potential candidates for the future design of antiparasitic drugs with a new mode of action.
Mangoni
Maria Luisa
ML
Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Scienze Biochimiche A. Rossi Fanelli, Azienda Ospedaliera S. Andrea, Italy. marialuisa.mangoni@uniroma1.it
Saugar
José M
JM
Dellisanti
Maria
M
Barra
Donatella
D
Simmaco
Maurizio
M
Rivas
Luis
L
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D023181:Antimicrobial Cationic Peptides; D000981:Antiprotozoal Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects / Q000254:growth & development; D002462:Cell Membrane / Q000187:drug effects; D002463:Cell Membrane Permeability; D004912:Erythrocytes / Q000166:cytology / Q000187:drug effects; D005456:Fluorescent Dyes; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D007891:Leishmania / Q000187:drug effects* / Q000254:growth & development / Q000502:physiology* / Q000648:ultrastructure; D008564:Membrane Potentials / Q000187:drug effects; D009930:Organic Chemicals; D010455:Peptides; D011506:Proteins / Q000494:pharmacology*; D011896:Rana temporaria
D000900:Anti-Bacterial Agents; D023181:Antimicrobial Cationic Peptides; D000981:Antiprotozoal Agents; D005456:Fluorescent Dyes; D009930:Organic Chemicals; D010455:Peptides; D011506:Proteins; C402795:SYTOX Green; C104501:temporin; D000255:Adenosine Triphosphate